The book “What is the bioeconomy” is finally here

The cover of the book

Climate change, population growth, soil degradation, biodiversity loss. These are the main challenges that humanity is called to face at the beginning of the millennium. The bioeconomy is one of the keys to tackling them and overcoming them, reconciling the economy, the environment and society. Based on the use of renewable biological resources as raw materials for industrial, energy, food and feed production, according to the European Union it has the potential to create at least one million jobs by 2030. The book that I wrote together with Irene Baños Ruiz aims at drawing a precise and up-to-date picture of the concept of bioeconomy, its origins, connections with sustainability and the circular economy and the multiple applications that we find in different products of our daily life.

I would like to thank particularly Philippe Mengal, executive director at BBI JU, and Marc Palahì, director at the European Forest Institute, who have written in a truly passionate way the foreword and the introduction of the book. Now “Che cosa è la bioeconomia” (What is the bioeconomy) is available only in Italian, soon also in English.

I would also like to thank all those who have accepted to be interviewed (Fabio Fava, Chris Patermann, Catia Bastioli, Massimo Centemero, Sandy Marshall, Mathieu Flamini, Jennifer Holmgren, Michael Carus and Frank Rijsberman) and in general all those who are making the sustainable and circular bioeconomy possible worldwide.

Mario Bonaccorso

 

New study: the market size of the Bioplastics will reach 3900 million dollars by 2023

Bio-on produced bioplastic used in this new version of Flos’ Miss Sissi lamp

According to Market Analyst, the Global Bioplastics Market is expected to grow at an impressive Compound Annual Growth Rate (CAGR) from 2019 to 2023. The market size of the Bioplastics will reach 3900 million $ by 2023, from 2960 million in 2018.

Continue reading

GranBio completed the acquisition of 100% equity in American Process

São Paolo, Brazil

Brazilian company GranBio completed the acquisition of 100% equity in American Process Inc. and affiliate companies including AVAPCO LLC and API Intellectual Properties Holdings. The acquired assets include the Alpena Biorefinery in Alpena Michigan, the Thomaston Biorefinery and R&D center in Thomaston, Georgia, operations, research, and business development staff and an extensive intellectual property portfolio in the biorefinery, biofuels, biochemicals, and nanocellulose fields with over 200 granted and pending patents.  Continue reading

BP, Virent Inc. and Johnson Matthey joined forces for production of bio-paraxylene

Image by MAKY OREL on Pixabay

BP, Virent Inc. and Johnson Matthey (JM) signed an agreement that will further advance the commercialization of Virent’s Bioforming® process for production of bio-paraxylene (PX), a key raw material for the production of renewable polyester.

Continue reading

International Women’s day: a tribute to all women who are making the bioeconomy happen

More and more women are protagonists of the bioeconomy. This year, as every year, for the International Women’s Day, we dedicate a tribute to all women who are making the bioeconomy happen all around the world. With their huge competences and their infinite passion, they are the stars of the world bioeconomy. Our best and warmest wishes to all women.

This is just a partial list.

Continue reading

DSM and Cargill established the Joint Venture Avansya

Royal DSM and Cargill established Avansya V.O.F. The 50:50 joint venture is a partnership between the two companies. Both parties announced their intention to establish this joint venture on 8 November 2018 subject to regulatory approvals. Avansya will produce zero-calorie, great-tasting sweeteners through fermentation and will be headquartered at the Biotech Campus Delft (Netherlands).

Continue reading

Nouryon and Gasunie supply green hydrogen to BioMCN to produce renewable methanol from CO2

Nouryon (formerly AkzoNobel Specialty Chemicals) and Gasunie have agreed to supply green hydrogen to BioMCN for the production of renewable methanol from CO2. The companies say it marks the next step in the sustainability of processes in the industry.

Continue reading

Anellotech takes a step forward in 100% renewable plastic bottle

David Sudolsky

U.S. sustainable technology company Anellotech and its joint development partners IFPEN and Axens have processed renewably-sourced aromatics made at Anellotech’s TCat- 8® pilot plant to successfully recover high-purity bio-based paraxylene – a key component for making 100% bio- based PET bottles a reality.

Continue reading

“We need to embrace genetic technologies”. An interview with William Cracroft-Eley, Terravesta

William Cracroft-Eley

“I also believe that we need to embrace genetic technologies, rather than be fearful of them, to enable the greatest beneficial outcomes in the shortest time”. To say it – in this interview with Il Bioeconomista – is William Cracroft-Eley, chairman of Terravesta, a leading miscanthus supply chain specialist, producing sustainable energy from marginal land. In this interview he talks about miscanthus and the role of farmers in the bioeconomy, the BBI JU Demo Project GRACE, “which is demonstrating the feasibility of 10 bio-based value chains for hemp and miscanthus biomass at an industry relevant scale”, the bioeconomy in UK after Brexit and the Vivergo’s case.

Interview by Mario Bonaccorso

Continue reading

The JV Reverdia will be dissolved effective 1 April 2019

Effective 1 April 2019, the joint venture between Royal DSM and Roquette, Reverdia, will be dissolved and the partners will transfer the rights and obligations related to Reverdia’s Biosuccinium® plant in Cassano, Italy to Roquette. Under a non-exclusive license from DSM, Roquette will operate the plant and continue serving customers of Biosuccinium®. Customer service, order processing, and marketing and sales will be integrated into Roquette’s existing business to ensure a smooth transition. DSM, the original developer of the Biosuccinium® technology, will assume the role of exclusive licensor, in line with its business model in this field.

Continue reading